33 Followers on Owler
OverviewCompetitorsAcquisitionsNews & Insights

Recordati Competitors or Alternatives

Recordati's top competitors include Zambon, Angelini and Famar.

Unlock 29 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Recordati's company profile

Robert Koremans

CEO

84/100
4,450
$0
$2.4B
  • $0
    $2.4B
  • 4,450
    $0
  • $2.4B
  • 84/100
  • 4,450
  • $0
  • $2.4B
View ProfileView
1
Recordati's Competitor - Zambon logo

Roberto Tascione

CEO

95/100
1,000 - 5,000
- -
$500M - 1B
  • - -
    $500M - 1B
  • 1,000 - 5,000
    - -
  • $500M - 1B
  • 95/100
  • 1,000 - 5,000
  • - -
  • $500M - 1B
View ProfileView
2
Recordati's Competitor - Angelini logo

Pierluigi Antonelli

CEO

50/100
1,000 - 5,000
- -
$1B - 5B
  • - -
    $1B - 5B
  • 1,000 - 5,000
    - -
  • $1B - 5B
  • 50/100
  • 1,000 - 5,000
  • - -
  • $1B - 5B
View ProfileView
3
Recordati's Competitor - Famar logo

Konstantinos Rengis

CEO

90/100
1,000 - 5,000
- -
$100M - 500M
  • - -
    $100M - 500M
  • 1,000 - 5,000
    - -
  • $100M - 500M
  • 90/100
  • 1,000 - 5,000
  • - -
  • $100M - 500M
View ProfileView
4
Recordati's Competitor - Genentech logo

Ashley Magargee

CEO

75/100
10,000 - 50,000
$2B
$10B - 50B
  • $2B
    $10B - 50B
  • 10,000 - 50,000
    $2B
  • $10B - 50B
  • 75/100
  • 10,000 - 50,000
  • $2B
  • $10B - 50B
View ProfileView
5
Recordati's Competitor - Shire logo

CEO

- -
10,000 - 50,000
- -
$10B - 50B
  • - -
    $10B - 50B
  • 10,000 - 50,000
    - -
  • $10B - 50B
  • - -
  • 10,000 - 50,000
  • - -
  • $10B - 50B
View ProfileView
Recordati's top 32 competitors are Zambon, Angelini, Famar, ViroStatics, Genentech, Shire, Ipsen, Pierrel, Pfizer, Novartis, Sanofi, Merck, Bayer , Amgen, Gilead, Johnson & Johnson, TEVA, AbbVie, Alize Pharma, Biogen, SOBI, Novo Nordisk, Boehringer Ingelheim, Athenex, Abbott, Mylan, Octapharma, Lilly, Alnylam, Cipla, BioMarin and Sangamo. Together they have raised over 57.5B between their estimated 1.1M employees. Recordati has 4,450 employees and is ranked 22th among it's top 10 competitors. The top 10 competitors average 35,062.

Recordati VS Zambon

Zambon is one of Recordati's top rivals. Zambon was founded in Bresso, Lombardy} in 1906. Like Recordati, Zambon also competes in the Pharmaceuticals space. Compared to Recordati, Zambon generates $1.5B less revenue.

Recordati VS Angelini

Angelini is Recordati's #2 competitor. Angelini was founded in 2008, and is headquartered in Rome, Lazio. Like Recordati, Angelini also operates in the Pharmaceuticals space. Angelini generates $1.1B less revenue vs. Recordati.

Recordati VS Famar

Famar is a top competitor of Recordati. Famar's headquarters is in Athens, Attica, and was founded in 1949. Like Recordati, Famar also works within the Pharmaceuticals sector. Famar generates 13% of Recordati's revenue.

Looking for similar companies to Recordati?

Similar Companies

Companies in Milan with revenue in $1.0-5.0B range

See 28 companies 
Pharmaceuticals companies in Lombardy

See 44 companies 
Companies in Milan with employees in 1.0-5.0K range

See 43 companies 
Companies in Lombardy with revenue in $1.0-5.0B range

See 52 companies 
Pharmaceuticals & Biotechnology companies in Lombardy

See 80 companies 
Companies in Lombardy with employees in 1.0-5.0K range

See 91 companies 
Pharmaceuticals companies in Milan

See 104 companies 
Pharmaceuticals companies with revenue in $1.0-5.0B range

See 143 companies 
Companies in Italy with revenue in $1.0-5.0B range

See 144 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Recordati and Recordati's Competitors

April 28, 2025FinanzNachrichten
RECORDATI: 2025-2027 THREE-YEAR PLAN APPROVED FY 2027 TARGETS OF REVENUE BETWEEN € 3,000 AND € 3,200 MILLION; EBITDA(1) BETWEEN € 1,140 AND € 1,225 MIL...
April 28, 2025Applied Clinical Trials
In the pivotal CREST clinical trial, sasanlimab in combination with Bacillus Calmette-Guérin met the primary endpoint of event-free survival....
Today 5:32 AMThe Wall Street Journal
Novartis raised its 2025 outlook after its core operating profit rose 23% on year, boosted by strong demand for its key drugs....
Today 6:38 AMPharmabiz
Merck, known as MSD outside of the United States and Canada, announced results from the phase 3 KEYNOTE─689 trial evaluating Keytruda (pembrolizumab), ...
April 28, 2025Pharmabiz
The European Medicines Agency (EMA) has recommended granting a marketing authorisation in the European Union (EU) for Tepezza (teprotumumab), for the t...
April 28, 2025Pharmabiz
Ipsen, will be presenting data from the late─breaking abstract on elafibranor in the investigational phase II ELMWOOD study at the European Association...
April 28, 2025The Hindu
April 28, 2025Chem Europe
The Bayer Group made major progress in a number of areas in 2024 and is actively taking steps to tackle the serious challenges it faces. "We're working...
April 28, 2025Medical Device Network
J&J submitted a New Drug Application to the FDA for TAR-200 in January 2025 following positive data from the SunRISe-1 trial. The post New data from J&...
April 28, 2025Nasdaq
Nearly everything looked great with AbbVie's (NYSE: ABBV) first-quarter results. The big drugmaker's revenue jumped 8.4% year over year, thanks largely...

Frequently Asked Questions about Recordati

  1. Who are Recordati's top competitors?

    Recordati's top 3 competitors are Zambon, Angelini, Famar.

  2. Who is similar to Recordati?

    Zambon is the most similar to Recordati. Angelini and Famar are also similar to Recordati.

  1. Are Recordati and Zambon competitors?

    Yes, Zambon is one of Recordati’s top competitors.